Novartis AG’s Global Head of Strategy, Stephen Moran, sat down with In Vivo to discuss pharma giant’s plans for a massive culture shift alongside a push for the increased use of big data, and plans to introduce innovative new drug platforms. Get a glimpse into Novartis’ strategy, which includes the launch of 13 new products through 2021, reducing costs in the next two years, and using value-based outcomes as a matter of standard procedure. Tap into insights around the company’s new strategy, as heard directly from the man tasked with overseeing its execution.
Schleifer, Yancopoulos And The $36 Billion Friendship
- Newsletter
- 4 Pages
- Global
